1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma
(
- Contribution to journal › Article
- 2017
-
Mark
Hepcidin levels and gastric cancer risk in the EPIC-EurGast study
(
- Contribution to journal › Article
-
Mark
Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans
(
- Contribution to journal › Article
- 2016
-
Mark
Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.
(
- Contribution to journal › Article
-
Mark
Prospective association of liver function biomarkers with development of hepatobiliary cancers.
(
- Contribution to journal › Article
-
Mark
Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
(
- Contribution to journal › Article
- 2015
-
Mark
Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.
(
- Contribution to journal › Article
-
Mark
Body iron status and gastric cancer risk in the EURGAST study.
(
- Contribution to journal › Article
-
Mark
Lag-times between lympho-proliferative disorder and clinical diagnosis of chronic lymphocytic leukemia (CLL): a prospective analysis using plasma soluble CD23.
(
- Contribution to journal › Article
-
Mark
Dietary Fat, Fat Subtypes and Hepatocellular Carcinoma in a Large European Cohort.
(
- Contribution to journal › Article